Insiders · HUMA

John Philip Bamforth

Director at Humacyte, Inc. (HUMA) since June 2024

John Philip Bamforth has filed 4 insider reports with the SEC since June 2024, as director at Humacyte, Inc. (HUMA). The latest filing, on June 12, 2026, reports grant or award at Humacyte, Inc. (HUMA).

Filings
4
Companies
1
Bought on market
None
Sold on market
None

Companies where John Philip Bamforth is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Humacyte, Inc. logo
HUMA
Humacyte, Inc.
Directorsince June 2024$0.4454Jun 12, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare John Philip Bamforth with

Other insiders at the same companies

Questions about John Philip Bamforth

What is John Philip Bamforth's role at Humacyte, Inc.?
John Philip Bamforth reports to the SEC as director at Humacyte, Inc. (HUMA), according to the latest filing on June 12, 2026.
Has John Philip Bamforth bought or sold stock recently?
No open-market purchases or sales by John Philip Bamforth are on file. The filings report grant or award.
How do I get alerts when John Philip Bamforth files?
Follow John Philip Bamforth on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by John Philip Bamforth (SEC CIK 0002026341). Totals count each trade once, skipping amendments whose original is on file, from Jun 17, 2024 on. View on SEC EDGAR · Get this as JSON